Aerocrine announces the positive outcome of its complaint against Medisoft in Germany Aerocrine AB today announced the positive final result of its complaint against Medisoft P.A.E. Filed at the District Court of Dusseldorf, Germany. The judgments could be appealed by Medisoft and Medisoft has announced to document invalidity proceedings against Aerocrine’s patents.Gevao, M.B., Ch.B., Thomas E. Fletcher, M.D., Robert A. Fowler, M.D., Daniel G. Bausch, M.D., M.P.H.T.M., Pardis C. Sabeti, M.D., D.Phil., S. Humarr Khan, M.B., Ch.B., and Robert F. Garry, Ph.D. For the KGH Lassa Fever Plan, the Viral Hemorrhagic Fever Consortium, and the WHO Clinical Response Team: Clinical Illness and Outcomes in Sufferers with Ebola in Sierra Leone The largest and most widespread outbreak of Ebola virus disease continues to spread through West Africa, with an increase of than 10,100 cases reported in Guinea, Sierra Leone, Liberia, Senegal, Nigeria, and Mali as of October 25, 2014.1 The possibility of global pass on of the condition was noticed recently with the medical diagnosis of EVD in patients in the United States and Spain.3,4 Sequence analyses indicated that the West African variant of Ebola virus diverged from Middle African lineages around ten years ago.5 Genetic similarity across the 2014 samples suggests an individual introduction from an animal reservoir, with human-to-human transmission sustaining the outbreak.